Skip to main content
NVDA-2.25%AAPL+1.57%GOOGL-0.06%MSFT+0.03%AMZN+0.06%TSM-1.07%SPCX+2.86%AVGO-0.14%META-0.24%TSLA-0.42%SKHY-3.56%MU-4.74%BRK-B-0.27%LLY+0.22%JPM-0.67%AMD-3.20%WMT+0.17%V-0.02%XOM+0.42%ASMLa-1.66%JNJ-0.47%INTC-4.99%MA-0.34%0700.HK-1.94%ORCL-2.93%1398.HK+0.79%BAC-0.62%ABBV+0.39%CSCO-0.88%CVX-0.17%COST+0.13%LRCX-4.58%KO+1.03%CAT-1.61%AMAT-2.27%0005.HK-0.78%AP2d-1.55%UNH-0.51%DELL-3.43%HSBA.L-1.30%MS-0.69%PG-0.16%GE-0.24%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.12%HD-1.18%GS-0.90%0939.HK+1.66%NZDJPY-2.59%AUDJPY-1.84%CHFJPY-1.57%NZDCAD-1.46%EURNZD+1.42%GBPNZD+1.37%USDJPY-1.32%NZDUSD-1.31%GBPJPY-1.24%EURJPY-1.21%CADJPY-1.14%NZDCHF-1.06%USDZAR+0.91%EURZAR+0.84%AUDNZD+0.78%GBPZAR+0.76%USDNOK+0.76%USDSEK+0.75%AUDCAD-0.73%EURNOK+0.69%EURSEK+0.68%AUDDKK-0.67%EURAUD+0.64%GBPAUD+0.59%CHFNOK+0.55%CHFSEK+0.54%AUDUSD-0.53%AUDSGD-0.52%USDTHB+0.48%USDMXN+0.44%GBPTRY+0.41%CADCHF+0.41%NZDSGD-0.37%EURCHF+0.35%NOKJPY-0.33%GBPHKD+0.32%GBPCHF+0.32%USDPLN+0.31%GBPMXN-0.28%AUDCHF-0.28%USDCHF+0.26%EURPLN+0.24%SGDJPY+0.21%USDSGD+0.21%USDILS+0.16%NZDMXN-0.16%USDCAD-0.16%EURSGD+0.14%GBPCAD-0.11%PLNJPY+0.11%USDTRY+0.11%EURUSD+0.09%EURCZK-0.08%EURHKD-0.08%USDCNH+0.08%GBPUSD+0.08%EURCAD-0.07%USDDKK+0.07%GBPSGD+0.05%EURGBP+0.04%USDCOP-0.04%EURCNH+0.03%AUDNOK+0.02%USDHKD+0.01%EURDKK0.00%CHFSGD0.00%XPTUSD-5.44%UKOIL+4.82%XAGUSD-4.74%HG1-4.74%GAGUSD-4.72%USOIL+4.60%SUGAR+2.62%GAUUSD-1.00%XAUUSD-0.99%COTTON+0.71%COFFEE-0.61%XNGUSD+0.61%BTCUSD-1.69%ETHUSD-1.16%USDTUSD-0.03%XRPUSD-3.13%SOLUSD-2.14%TRXUSDT-0.03%ZECUSDT-7.21%DOGEUSD-3.27%XMRUSDT-1.52%LINKUSD-1.88%XLMUSD-2.42%BCHUSDT-10.66%LTCUSD-2.36%UNIUSD-3.05%TONUSD+24.88%HBARUSDT-2.57%SUIUSD-4.11%TAOUSDT-5.96%AAVEUSD-3.34%DOTUSDT-3.52%ICPUSDT-1.44%ONDOUSDT-3.87%WLDUSDT-3.39%ARBUSDT-0.46%ATOMUSDT-5.13%JUPUSDT-4.25%INJUSDT-5.65%STXUSDT-4.53%FETUSDT-4.15%TIAUSDT-2.18%PYTHUSDT-1.47%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-2.91%WIFUSDT-5.87%OPUSDT-4.00%POLUSDT-6.03%IOTAUSDT-4.48%AXSUSDT-2.90%FARTCOINUSDT-4.41%EOSUSDT-1.67%DYDXUSDT-3.58%ORDIUSDT-1.88%GALAUSDT-4.78%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.25%AAPL+1.57%GOOGL-0.06%MSFT+0.03%AMZN+0.06%TSM-1.07%SPCX+2.86%AVGO-0.14%META-0.24%TSLA-0.42%SKHY-3.56%MU-4.74%BRK-B-0.27%LLY+0.22%JPM-0.67%AMD-3.20%WMT+0.17%V-0.02%XOM+0.42%ASMLa-1.66%JNJ-0.47%INTC-4.99%MA-0.34%0700.HK-1.94%ORCL-2.93%1398.HK+0.79%BAC-0.62%ABBV+0.39%CSCO-0.88%CVX-0.17%COST+0.13%LRCX-4.58%KO+1.03%CAT-1.61%AMAT-2.27%0005.HK-0.78%AP2d-1.55%UNH-0.51%DELL-3.43%HSBA.L-1.30%MS-0.69%PG-0.16%GE-0.24%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.12%HD-1.18%GS-0.90%0939.HK+1.66%NZDJPY-2.59%AUDJPY-1.84%CHFJPY-1.57%NZDCAD-1.46%EURNZD+1.42%GBPNZD+1.37%USDJPY-1.32%NZDUSD-1.31%GBPJPY-1.24%EURJPY-1.21%CADJPY-1.14%NZDCHF-1.06%USDZAR+0.91%EURZAR+0.84%AUDNZD+0.78%GBPZAR+0.76%USDNOK+0.76%USDSEK+0.75%AUDCAD-0.73%EURNOK+0.69%EURSEK+0.68%AUDDKK-0.67%EURAUD+0.64%GBPAUD+0.59%CHFNOK+0.55%CHFSEK+0.54%AUDUSD-0.53%AUDSGD-0.52%USDTHB+0.48%USDMXN+0.44%GBPTRY+0.41%CADCHF+0.41%NZDSGD-0.37%EURCHF+0.35%NOKJPY-0.33%GBPHKD+0.32%GBPCHF+0.32%USDPLN+0.31%GBPMXN-0.28%AUDCHF-0.28%USDCHF+0.26%EURPLN+0.24%SGDJPY+0.21%USDSGD+0.21%USDILS+0.16%NZDMXN-0.16%USDCAD-0.16%EURSGD+0.14%GBPCAD-0.11%PLNJPY+0.11%USDTRY+0.11%EURUSD+0.09%EURCZK-0.08%EURHKD-0.08%USDCNH+0.08%GBPUSD+0.08%EURCAD-0.07%USDDKK+0.07%GBPSGD+0.05%EURGBP+0.04%USDCOP-0.04%EURCNH+0.03%AUDNOK+0.02%USDHKD+0.01%EURDKK0.00%CHFSGD0.00%XPTUSD-5.44%UKOIL+4.82%XAGUSD-4.74%HG1-4.74%GAGUSD-4.72%USOIL+4.60%SUGAR+2.62%GAUUSD-1.00%XAUUSD-0.99%COTTON+0.71%COFFEE-0.61%XNGUSD+0.61%BTCUSD-1.69%ETHUSD-1.16%USDTUSD-0.03%XRPUSD-3.13%SOLUSD-2.14%TRXUSDT-0.03%ZECUSDT-7.21%DOGEUSD-3.27%XMRUSDT-1.52%LINKUSD-1.88%XLMUSD-2.42%BCHUSDT-10.66%LTCUSD-2.36%UNIUSD-3.05%TONUSD+24.88%HBARUSDT-2.57%SUIUSD-4.11%TAOUSDT-5.96%AAVEUSD-3.34%DOTUSDT-3.52%ICPUSDT-1.44%ONDOUSDT-3.87%WLDUSDT-3.39%ARBUSDT-0.46%ATOMUSDT-5.13%JUPUSDT-4.25%INJUSDT-5.65%STXUSDT-4.53%FETUSDT-4.15%TIAUSDT-2.18%PYTHUSDT-1.47%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-2.91%WIFUSDT-5.87%OPUSDT-4.00%POLUSDT-6.03%IOTAUSDT-4.48%AXSUSDT-2.90%FARTCOINUSDT-4.41%EOSUSDT-1.67%DYDXUSDT-3.58%ORDIUSDT-1.88%GALAUSDT-4.78%NOTUSDT-2.97%RONINUSDT-2.64%
AT

Aquestive Therapeutics, Inc. (AQST)

NASDAQ • Healthcare

$5.15
-$0.05 (-1.2%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$5.22
Previous Close$5.15
Day Range$5.07 - $5.25
Avg. Volume (3M)3.4M
Market Cap$646.1M
52 Week Range
$2.93$7.55
Next EarningsIn 55 daysNov 4, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$13.8M100%
Gross Profitminus cost of goods$9.8M71%

Fundamentals & Financials

Revenue (TTM)
$54M
Net Income (TTM)
-$78.2M
EPS (TTM)
-$0.65
ROA (TTM)
-59.22%
Current Ratio
7.19

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-100.0%Q1 2026-$0.26
+50.0%Q2 2026-$0.07
-71.4%Q3 2026-$0.18
Next

Nov 4

in 55 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -71.4%

Aquestive Therapeutics’ results for the second fiscal quarter of 2026 missed expectations on earnings, with EPS of -$0.18 trailing the -$0.10 estimate by -$0.07, in results reported August 11, 2026. Revenue rose 38% year over year to about $13.8 million, up from roughly $10.0 million a year ago, alongside gross profit of about $9.8 million as gross margin ran near 71%. Operating results remained negative, with operating income of roughly -$8.2 million and operating margin around -60%, while the bottom line posted net income of about -$22.9 million versus roughly -$13.5 million a year ago. On a per-share basis, EPS was down 29% from -$0.14 a year earlier. Cash generation was also negative, with operating cash flow of roughly -$9.4 million in the quarter. Next-period consensus calls for EPS of -$0.11 on revenue of $11.0 million.

View full earnings history

About Aquestive Therapeutics, Inc.

Aquestive Therapeutics, Inc. (NASDAQ: AQST) develops and commercializes specialty pharmaceutical products built around oral, buccal, and sublingual film delivery, operating in the drug manufacturing business. Its portfolio spans marketed therapies and pipeline candidates aimed at unmet medical needs, and it generated $44.5 million of revenue in FY2025.

Name
Aquestive Therapeutics, Inc.
CEO
Daniel Barber
Website
www.aquestive.com
Industry
Healthcare
Year Founded
2004
Employees
147

Today's Snapshot

AI-generated

AQST started the session slightly lower at 5.13, while its sector was flat. Cantor Fitzgerald, an investment bank, kept its positive rating on Aquestive over Anaphylm, its epinephrine product.

Trading Volume

Below 10d avg (2.0M)

591.5K

vs S&P 500 Today

Strong Outperformance

+3.08%

Updated: September 10, 2026 at 14:59 UTC

Technical Indicators

6 Buy2 Neutral0 Sell
AQST’s technicals present a strong-buy picture with a robust trend and consistent moving-average support. ADX above 40 confirms a strong directional move, MACD is in buy mode, and the stock trades above its short, medium and 200-day averages while the classic pivot sits slightly lower. Oscillators are broadly constructive and ATR shows contained volatility in the mid-single-digit percent range. Despite a negative OBV figure that appears at odds with price strength, the internals remain largely bullish. Technical takeaway: Strong Buy—trend and moving averages support strength, but volume merits monitoring.
All signals
  • EMA (5 indicators)$4.45 - $5.17
    Buy
  • RSI (14)64.52
    Neutral
  • Stochastic %K (14, 3, 3)73.71
    Neutral
  • MACD Level (12, 26)0.29
    Buy

Peers & Related Assets

ERASErasca, Inc.
$15.7-3.6%
ESPREsperion Therapeutics, Inc.
$3.180.0%
ARVNArvinas, Inc.
$8.76-3.5%
OFIXOrthofix Medical Inc.
$8.91-2.6%
EBSEmergent BioSolutions Inc.
$5.68-5.3%
AVXLAnavex Life Sciences Corp.
$2.75-3.5%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.